Safety profiles of biosimilars vs. their EU reference products: INNs (adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, etanercept). - Kopanarov, Valentin; Benisheva, Tatyana; Naydenova, Radoslava; Gergova, Veska; Dimitrov, Dimitar; Sidjimova, Dobriana; Mateev, Hristo (Biotechnology & Biotechnological Equipment, 2025)